Case Report
Copyright ©The Author(s) 2020.
World J Clin Oncol. Jul 24, 2020; 11(7): 495-503
Published online Jul 24, 2020. doi: 10.5306/wjco.v11.i7.495
Figure 2
Figure 2 Comparison between baseline positron emission tomography scans (A, left) and after 4 mo of crizotinib treatment (B, right). A: Before treatment, thyroid, pulmonary, ganglion and bone hypermetabolic spots; B: Complete metabolic response with condensing bone metastases without significant hypermetabolism.